Efbemalenograstim Alfa Injection
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Efbemalenograstim Alfa Injection, covering 2024-05-07 to 2024-10-18. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. [NA]